Language
~Unleashing the functions of biomaterials with amoeba hydrogel~
Business Model
~How to proceed with collaboration~
Improving the efficiency of existing reaction processes,
The probability of a process such as flow synthesis is
We provide support from test scale to commercialization.
Feasibility Study
Planning consultation and initial evaluation
Check compatibility with your biological materials using established standard samples.
We provide standard protocols, which are our know-how, and provide consulting on evaluation methods, etc.
We will explore specific future directions.
Conditions: We will conclude an NDA, CDA, etc. to manage each other's confidential information.
Cost: Negotiable depending on the service content, sample quantity and timing.
Duration: Approximately 3 months (after signing NDA, etc.).
Joint research and development
Under a one-year contract, we will work together to tackle specific issues in more detail. We will also consider tuning the composition, and the necessity and methods of immobilization and modification. We will also individually or jointly develop evaluation methods.
Conditions: We will enter into a joint research and development agreement and manage each other's confidential information, rights, etc.
Cost: Negotiable depending on the content of the study and resources.
Period: One year (after the contract is signed).
Considering scale-up and mass production
Both parties will consider scaling up with a view to mass production. We will finalize the production technology and commercial conditions for commercialization, and verify cost estimates and royalty settings associated with mass production benefits. We will also specifically consider the supply of materials.
Conditions: A joint development agreement will be concluded and both parties will manage each other's confidential information and rights, including the production process.
Cost: Negotiable depending on the content of the study, resources, etc.
Period: One year (after the contract is signed).
Licensing
Through licensing, we hope to build lasting relationships with our customers.
Through our royalty relationship, we hope to become a partner that not only supplies materials and solves immediate problems, but also works together to find better solutions that contribute to sustainable growth.
Many patents have been granted and patents are pending.
We are currently responding to developments and providing exclusive licenses to chemical and pharmaceutical companies.
We are incorporating knowledge of machine learning from the University of Tokyo to enable ultra-fast polymer design for a variety of applications.
